Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant

  1. Toni L. Williamson*,
  2. Lucie I. Bruijn*,
  3. Qinzhang Zhu,
  4. Karen L. Anderson*,
  5. Scott D. Anderson*,
  6. Jean-Pierre Julien, and
  7. Don W. Cleveland*,,§
  1. *Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Centre For Research in Neuroscience, McGill University, The Montreal General Hospital, Montreal H3G 1A4, Canada
  1. Communicated by Elaine Fuchs, The University of Chicago, Chicago, IL (received for review May 15, 1998)

Abstract

Mutations in superoxide dismutase 1 (SOD1), the only proven cause of amyotrophic lateral sclerosis (ALS), provoke disease through an unidentified toxic property. Neurofilament aggregates are pathologic hallmarks of both sporadic and SOD1-mediated familial ALS. By deleting NF-L, the major neurofilament subunit required for filament assembly, onset and progression of disease caused by familial ALS-linked SOD1 mutant G85R are significantly slowed, while selectivity of mutant-mediated toxicity for motor neurons is reduced. In NF-L-deleted animals, levels of the two remaining neurofilament subunits, NF-M and NF-H, are markedly reduced in axons but are elevated in motor neuron cell bodies. Thus, while neither perikaryal nor axonal neurofilaments are essential for SOD1-mediated disease, the absence of assembled neurofilaments both diminishes selective vulnerability and slows SOD1G85R mutant-mediated toxicity to motor neurons.

Footnotes

  • § To whom reprint requests should be addressed at: Ludwig Institute for Cancer Research, 9500 Gilman Drive, La Jolla, CA 92093. e-mail: dcleveland{at}uscd.edu.

  • ABBREVIATIONS:
    ALS,
    amyotrophic lateral sclerosis;
    FALS,
    familial ALS;
    SOD1,
    superoxide dismutase 1
« Previous | Next Article »Table of Contents